Plexus (PLXS) stock surged 5.23% during intraday trading on Friday, reflecting strong investor optimism following positive analyst actions.
The sharp price increase appears to be driven by several analyst firms raising their price targets for the company. Needham increased its target to $206 from $165 while maintaining a Buy rating, Stifel raised its target to $200 from $150, and Benchmark lifted its target to $220 from $195. These significant upward revisions in price targets suggest growing confidence in Plexus's prospects among Wall Street analysts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.